Showing results (331-340 of 388) with videos related to

Sort By:
Pageof 39
Forensic Science International|March 18, 2006
Automated PCR setup for forensic casework samples using the Normalization Wizard and PCR Setup robotic methodsS A Greenspoon, K L V Sykes, J D Ban, et al.
Advanced Materials (Deerfield Beach, Fla.)|July 13, 2026
Uniaxial Stress Enhanced Anisotropic Magnetoresistance and Superconductivity in the Kagome Superconductor LaRu3Si2P Kral, V Sazgari, Y Ge, et al.
Trials|July 26, 2022
The APPLE Tree programme: Active Prevention in People at risk of dementia through Lifestyle, bEhaviour change and Technology to build REsiliEnce-randomised controlled trialM Poppe, L Duffy, N L Marchant, et al.
Bioorganic & Medicinal Chemistry Letters|August 18, 1999
4-hydroxy-5,6-dihydro-2H-pyran-2-ones.3. Bicyclic and hetero-aromatic ring systems as 3-position scaffolds to bind to S1' and S2' of the HIV-1 protease enzymeE L Ellsworth, J Domagala, J V Prasad, et al.
Medical Care|June 3, 2015
Quality of Care for Chronic Conditions Among Disabled Medicaid Enrollees: An Evaluation of a 1915 (b) and (c) Waiver ProgramMartin P Wegman, Jill B Herndon, Keith E Muller, et al.
Communications Physics|November 11, 2024
Unveiling nodeless unconventional superconductivity proximate to honeycomb-vacancy ordering in the Ir-Sb binary systemV Sazgari, T P Ying, J N Graham, et al.
Cognitive Behaviour Therapy|November 20, 2025
Comparing evidence-based telemental health treatments for caregivers of children with Prader Willi and Williams syndromes: feasibility, acceptability, and preliminary outcomesLyndsey N Graham, Veronika Vozka, Dan Foti, et al.
Journal of Robotic Surgery|August 25, 2021
Implementation of a multimodal opioid-sparing enhanced recovery pathway for robotic-assisted radical prostatectomyAkbar N Ashrafi, Wesley Yip, John N Graham, et al.
Brain Communications|November 29, 2023
Active elite rugby participation is associated with altered precentral cortical thicknessThomas D Parker, Karl A Zimmerman, Etienne Laverse, et al.
ESMO Open|June 4, 2024
Phase Ib dose-escalation trial of taselisib (GDC-0032) in combination with HER2-directed therapies in patients with advanced HER2+ breast cancerA Grinshpun, S Ren, N Graham, et al.
Pageof 39